• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Study reveals why some patients with the hereditary disease remain healthy

April 17, 2025
in Medical Research
Reading Time: 5 mins read
A A
0
Alpha-1 antitrypsin deficiency: What protects the one – and not the other?
4
SHARES
9
VIEWS
Share on FacebookShare on Twitter


Alpha-1 antitrypsin deficiency: What protects the one – and not the other?
Microscopic image of a human liver biopsy. Alpha-1 aggregates in yellow, liver cells in gray with blue nucleus. Credit: MPI of Biochemistry/ Florian Rosenberger

Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This regulation is crucial, and an overactive immune response can cause serious lung diseases.

However, some individuals carry a genetic mutation that causes the alpha-1 protein to fold incorrectly. As a result, too little functional alpha-1 is produced, and insufficient amounts reach the lungs.

The mutation is inherited from one or both parents. About 1 in 20 people in Europe carry the heterozygous form of the mutation—inherited from only one parent—and often experience no symptoms or only mild ones. In contrast, the rarer homozygous form, inherited from both parents, affects approximately 1 in 2,000 individuals and is much more severe.

These patients are at a higher risk of developing not only lung disease, such as chronic obstructive pulmonary disease (COPD), but also liver complications including severe fibrosis or even tumors.

One mutation, divergent paths

An international research team led by Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried, near Munich, has now uncovered important new insights into the homozygous form of the condition. The findings are published in the journal Nature.

First author Florian Rosenberger, from the Department of Proteomics and Signal Transduction, explains, “In the homozygous form, something striking stands out. It is a monogenetic disease, meaning all patients carry the same mutation—so in theory, disease progression should be uniform. But that’s not what we see.

“One-third of patients develop severe liver fibrosis, where connective tissue accumulates and impairs liver function. Two-thirds, however, remain healthy. We wanted to understand why that is. What molecular mechanisms protect some patients while others develop disease?”

The team used a technique called Deep Visual Proteomics, developed collaboratively in Martinsried and Copenhagen by the proteomics research groups of Matthias Mann. This method applies advanced proteome analysis to identify disease mechanisms. For the Alpha-1 study, liver tissue samples from patients in Germany and Denmark were analyzed.

“We examined tissue across the full spectrum of disease stages,” Rosenberger continues. “Even in early stages—when clinical signs had not yet appeared—we could observe how the body in some cases successfully halted disease progression.”

For their analysis, the researchers employed a convolutional neural network (CNN)—a form of artificial intelligence originally trained to recognize faces and everyday objects in images.

Subtle differences with big impacts

The CNN also performed impressively on images of human liver tissue. It was able to differentiate between subtle structural variations in the disease, particularly the way alpha-1 protein aggregates in liver cells (hepatocytes). These aggregates are a hallmark of disease onset. “Our CNN could detect extremely fine differences in aggregate morphology,” says Rosenberger.

Two distinct forms stood out: crumb-like aggregates with a rough, irregular structure, and ball-like aggregates with a more defined appearance. This raised a key question: what determines which type appears—and are they random or biologically meaningful?

This is where the team made a breakthrough. They successfully reconstructed the sequence of molecular events—the formation of crumbs, balls, and the transitions between them—and identified their temporal order.

The crumb-like aggregates appeared first, as an early response of stressed cells. This was associated with activity in special cell compartments called peroxisomes. The ball-like aggregates emerged later, during more advanced stages of fibrosis.

Interestingly, however, the type of aggregate did not always correlate with disease severity. Even patients with only mild fibrosis could show the advanced ball-like morphology. “The shift from crumbs to balls was a key finding,” Rosenberger explains. “It reveals the sequence of compensatory responses liver cells mount in an effort to combat aggregate formation—and with it, liver fibrosis.”

Toward clinical applications

The improved AI-based image analysis played a pivotal role in uncovering these mechanisms. “Recent technological advances in mass spectrometry were crucial,” says Professor Mann. “We can now perform single-cell measurements, allowing us to extract detailed molecular information from just a small amount of tissue—even from individual diseased liver cells.”

The study’s findings may soon have clinical relevance. The development of fibrosis in individuals with the homozygous mutation could potentially be prevented.

“By reviewing patient histories, we saw that those with severe fibrosis lacked the early peroxisomal response,” says Rosenberger. “We now know this response is protective. Our goal is to develop an early warning system for liver fibrosis—a way to identify patients at risk before symptoms arise.”

Aleksander Krag, professor at the University of Southern Denmark and head of Odense Liver Research Center, emphasizes, “By capturing alpha-1 antitrypsin accumulation at the single-cell level, we have uncovered early molecular triggers of how alpha-1 antitrypsin deficiency progresses. This points toward actionable targets that could lead to improved therapies for patients.”

Pavel Strnad, a hepatologist at University Hospital Aachen and long-standing collaborator on the project, adds, “Erroneous protein folding is central to many human diseases, including Parkinson’s and Alzheimer’s. Studying a monogenic condition like Alpha-1 antitrypsin deficiency provides a unique opportunity to better understand disease progression.

“This work deepens our insight into protein folding disorders and their consequences, and will be important even beyond Alpha-1 antitrypsin deficiency.”

More information:
Florian A. Rosenberger et al, Deep Visual Proteomics maps proteotoxicity in a genetic liver disease, Nature (2025). DOI: 10.1038/s41586-025-08885-4

Provided by
Max Planck Society


Citation:
Alpha-1 antitrypsin deficiency: Study reveals why some patients with the hereditary disease remain healthy (2025, April 17)
retrieved 17 April 2025
from https://medicalxpress.com/news/2025-04-alpha-antitrypsin-deficiency-reveals-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Alpha-1 antitrypsin deficiency: What protects the one – and not the other?
Microscopic image of a human liver biopsy. Alpha-1 aggregates in yellow, liver cells in gray with blue nucleus. Credit: MPI of Biochemistry/ Florian Rosenberger

Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This regulation is crucial, and an overactive immune response can cause serious lung diseases.

However, some individuals carry a genetic mutation that causes the alpha-1 protein to fold incorrectly. As a result, too little functional alpha-1 is produced, and insufficient amounts reach the lungs.

The mutation is inherited from one or both parents. About 1 in 20 people in Europe carry the heterozygous form of the mutation—inherited from only one parent—and often experience no symptoms or only mild ones. In contrast, the rarer homozygous form, inherited from both parents, affects approximately 1 in 2,000 individuals and is much more severe.

These patients are at a higher risk of developing not only lung disease, such as chronic obstructive pulmonary disease (COPD), but also liver complications including severe fibrosis or even tumors.

One mutation, divergent paths

An international research team led by Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried, near Munich, has now uncovered important new insights into the homozygous form of the condition. The findings are published in the journal Nature.

First author Florian Rosenberger, from the Department of Proteomics and Signal Transduction, explains, “In the homozygous form, something striking stands out. It is a monogenetic disease, meaning all patients carry the same mutation—so in theory, disease progression should be uniform. But that’s not what we see.

“One-third of patients develop severe liver fibrosis, where connective tissue accumulates and impairs liver function. Two-thirds, however, remain healthy. We wanted to understand why that is. What molecular mechanisms protect some patients while others develop disease?”

The team used a technique called Deep Visual Proteomics, developed collaboratively in Martinsried and Copenhagen by the proteomics research groups of Matthias Mann. This method applies advanced proteome analysis to identify disease mechanisms. For the Alpha-1 study, liver tissue samples from patients in Germany and Denmark were analyzed.

“We examined tissue across the full spectrum of disease stages,” Rosenberger continues. “Even in early stages—when clinical signs had not yet appeared—we could observe how the body in some cases successfully halted disease progression.”

For their analysis, the researchers employed a convolutional neural network (CNN)—a form of artificial intelligence originally trained to recognize faces and everyday objects in images.

Subtle differences with big impacts

The CNN also performed impressively on images of human liver tissue. It was able to differentiate between subtle structural variations in the disease, particularly the way alpha-1 protein aggregates in liver cells (hepatocytes). These aggregates are a hallmark of disease onset. “Our CNN could detect extremely fine differences in aggregate morphology,” says Rosenberger.

Two distinct forms stood out: crumb-like aggregates with a rough, irregular structure, and ball-like aggregates with a more defined appearance. This raised a key question: what determines which type appears—and are they random or biologically meaningful?

This is where the team made a breakthrough. They successfully reconstructed the sequence of molecular events—the formation of crumbs, balls, and the transitions between them—and identified their temporal order.

The crumb-like aggregates appeared first, as an early response of stressed cells. This was associated with activity in special cell compartments called peroxisomes. The ball-like aggregates emerged later, during more advanced stages of fibrosis.

Interestingly, however, the type of aggregate did not always correlate with disease severity. Even patients with only mild fibrosis could show the advanced ball-like morphology. “The shift from crumbs to balls was a key finding,” Rosenberger explains. “It reveals the sequence of compensatory responses liver cells mount in an effort to combat aggregate formation—and with it, liver fibrosis.”

Toward clinical applications

The improved AI-based image analysis played a pivotal role in uncovering these mechanisms. “Recent technological advances in mass spectrometry were crucial,” says Professor Mann. “We can now perform single-cell measurements, allowing us to extract detailed molecular information from just a small amount of tissue—even from individual diseased liver cells.”

The study’s findings may soon have clinical relevance. The development of fibrosis in individuals with the homozygous mutation could potentially be prevented.

“By reviewing patient histories, we saw that those with severe fibrosis lacked the early peroxisomal response,” says Rosenberger. “We now know this response is protective. Our goal is to develop an early warning system for liver fibrosis—a way to identify patients at risk before symptoms arise.”

Aleksander Krag, professor at the University of Southern Denmark and head of Odense Liver Research Center, emphasizes, “By capturing alpha-1 antitrypsin accumulation at the single-cell level, we have uncovered early molecular triggers of how alpha-1 antitrypsin deficiency progresses. This points toward actionable targets that could lead to improved therapies for patients.”

Pavel Strnad, a hepatologist at University Hospital Aachen and long-standing collaborator on the project, adds, “Erroneous protein folding is central to many human diseases, including Parkinson’s and Alzheimer’s. Studying a monogenic condition like Alpha-1 antitrypsin deficiency provides a unique opportunity to better understand disease progression.

“This work deepens our insight into protein folding disorders and their consequences, and will be important even beyond Alpha-1 antitrypsin deficiency.”

More information:
Florian A. Rosenberger et al, Deep Visual Proteomics maps proteotoxicity in a genetic liver disease, Nature (2025). DOI: 10.1038/s41586-025-08885-4

Provided by
Max Planck Society


Citation:
Alpha-1 antitrypsin deficiency: Study reveals why some patients with the hereditary disease remain healthy (2025, April 17)
retrieved 17 April 2025
from https://medicalxpress.com/news/2025-04-alpha-antitrypsin-deficiency-reveals-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Election officials’ discussion of uncounted ballots devolves into shouting match

Next Post

What is the Flatside wilderness of Arkansas?

Related Posts

bmi

The greater a woman’s BMI in early pregnancy, the more likely her child is to develop overweight or obesity, study finds

May 9, 2025
2

Trump Once Vowed To End HIV in America. His Funding Cuts Are Rolling Back Progress.

May 9, 2025
5
Next Post
What is the Flatside wilderness of Arkansas?

What is the Flatside wilderness of Arkansas?

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
Donald Trump delivering remarks to reporters.

President Donald Trump Just Called for a Drastic Social Security Change — but It Comes With Unintended Consequences todayheadline

May 10, 2025
European leaders arrive in Kyiv to show support after Putin's parade

European leaders arrive in Kyiv to show support after Putin's parade todayheadline

May 10, 2025

India slams IMF on repeated Pakistan loans, questions effectiveness todayheadline

May 10, 2025
a black and white rocket rests on the deck of a ship at sea at night

SpaceX launches 28 Starlink satellites to orbit from Florida

May 10, 2025

Recent News

Donald Trump delivering remarks to reporters.

President Donald Trump Just Called for a Drastic Social Security Change — but It Comes With Unintended Consequences todayheadline

May 10, 2025
3
European leaders arrive in Kyiv to show support after Putin's parade

European leaders arrive in Kyiv to show support after Putin's parade todayheadline

May 10, 2025
3

India slams IMF on repeated Pakistan loans, questions effectiveness todayheadline

May 10, 2025
4
a black and white rocket rests on the deck of a ship at sea at night

SpaceX launches 28 Starlink satellites to orbit from Florida

May 10, 2025
3

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

Donald Trump delivering remarks to reporters.

President Donald Trump Just Called for a Drastic Social Security Change — but It Comes With Unintended Consequences todayheadline

May 10, 2025
European leaders arrive in Kyiv to show support after Putin's parade

European leaders arrive in Kyiv to show support after Putin's parade todayheadline

May 10, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co